Interaction of chronic ethanol exposure and finasteride: Sex and strain differences

Deborah (Deb) Finn, Season L. Long, Michelle A. Tanchuck, John Jr Crabbe

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The neurosteroid allopregnanolone (ALLOP) is a very potent positive modulator of γ-aminobutyric acidA (GABAA) receptors that can modulate ethanol (EtOH) withdrawal. The 5α-reductase inhibitor finasteride blocks the formation of ALLOP from progesterone and was recently found to reduce some effects of EtOH. Thus, the present studies were conducted to determine the effect of finasteride on chronic EtOH withdrawal severity in male and female C57BL/6 (B6) and DBA/2 (D2) mice. The animals were exposed to 72 h EtOH vapor or air and received four injections of finasteride (50 mg/kg ip) 24 h prior to, and each day of, the EtOH vapor exposure. Upon removal from the inhalation chambers, handling-induced convulsions (HICs) were measured hourly for the first 12 h and then again at 24 h. EtOH withdrawal severity was significantly greater in D2 than in B6 mice. Pretreatment with finasteride significantly decreased EtOH withdrawal severity only in the female D2 mice, produced a nonselective suppressive effect on HIC in male B6 and D2 mice, and did not significantly alter HIC in female B6 mice. Finasteride pretreatment significantly decreased blood EtOH concentration (BEC) upon initiation of withdrawal, suggesting that finasteride may affect withdrawal severity via an alteration in EtOH pharmacokinetics.

Original languageEnglish (US)
Pages (from-to)435-443
Number of pages9
JournalPharmacology Biochemistry and Behavior
Volume78
Issue number3
DOIs
StatePublished - Jul 2004

Fingerprint

Finasteride
Sex Characteristics
Ethanol
Inbred DBA Mouse
Pregnanolone
Seizures
Vapors
Pharmacokinetics
GABA-A Receptors
Inhalation
Modulators
Progesterone
Neurotransmitter Agents
Oxidoreductases
Animals
Blood
Air
Injections

Keywords

  • 5α-reductase
  • Allopregnanolone
  • C57BL/6
  • DBA/2
  • Handling-induced convulsions
  • Neurosteroid
  • Withdrawal

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Interaction of chronic ethanol exposure and finasteride : Sex and strain differences. / Finn, Deborah (Deb); Long, Season L.; Tanchuck, Michelle A.; Crabbe, John Jr.

In: Pharmacology Biochemistry and Behavior, Vol. 78, No. 3, 07.2004, p. 435-443.

Research output: Contribution to journalArticle

@article{11a9ce8e56e34f1987d413a67725ff74,
title = "Interaction of chronic ethanol exposure and finasteride: Sex and strain differences",
abstract = "The neurosteroid allopregnanolone (ALLOP) is a very potent positive modulator of γ-aminobutyric acidA (GABAA) receptors that can modulate ethanol (EtOH) withdrawal. The 5α-reductase inhibitor finasteride blocks the formation of ALLOP from progesterone and was recently found to reduce some effects of EtOH. Thus, the present studies were conducted to determine the effect of finasteride on chronic EtOH withdrawal severity in male and female C57BL/6 (B6) and DBA/2 (D2) mice. The animals were exposed to 72 h EtOH vapor or air and received four injections of finasteride (50 mg/kg ip) 24 h prior to, and each day of, the EtOH vapor exposure. Upon removal from the inhalation chambers, handling-induced convulsions (HICs) were measured hourly for the first 12 h and then again at 24 h. EtOH withdrawal severity was significantly greater in D2 than in B6 mice. Pretreatment with finasteride significantly decreased EtOH withdrawal severity only in the female D2 mice, produced a nonselective suppressive effect on HIC in male B6 and D2 mice, and did not significantly alter HIC in female B6 mice. Finasteride pretreatment significantly decreased blood EtOH concentration (BEC) upon initiation of withdrawal, suggesting that finasteride may affect withdrawal severity via an alteration in EtOH pharmacokinetics.",
keywords = "5α-reductase, Allopregnanolone, C57BL/6, DBA/2, Handling-induced convulsions, Neurosteroid, Withdrawal",
author = "Finn, {Deborah (Deb)} and Long, {Season L.} and Tanchuck, {Michelle A.} and Crabbe, {John Jr}",
year = "2004",
month = "7",
doi = "10.1016/j.pbb.2004.04.016",
language = "English (US)",
volume = "78",
pages = "435--443",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Interaction of chronic ethanol exposure and finasteride

T2 - Sex and strain differences

AU - Finn, Deborah (Deb)

AU - Long, Season L.

AU - Tanchuck, Michelle A.

AU - Crabbe, John Jr

PY - 2004/7

Y1 - 2004/7

N2 - The neurosteroid allopregnanolone (ALLOP) is a very potent positive modulator of γ-aminobutyric acidA (GABAA) receptors that can modulate ethanol (EtOH) withdrawal. The 5α-reductase inhibitor finasteride blocks the formation of ALLOP from progesterone and was recently found to reduce some effects of EtOH. Thus, the present studies were conducted to determine the effect of finasteride on chronic EtOH withdrawal severity in male and female C57BL/6 (B6) and DBA/2 (D2) mice. The animals were exposed to 72 h EtOH vapor or air and received four injections of finasteride (50 mg/kg ip) 24 h prior to, and each day of, the EtOH vapor exposure. Upon removal from the inhalation chambers, handling-induced convulsions (HICs) were measured hourly for the first 12 h and then again at 24 h. EtOH withdrawal severity was significantly greater in D2 than in B6 mice. Pretreatment with finasteride significantly decreased EtOH withdrawal severity only in the female D2 mice, produced a nonselective suppressive effect on HIC in male B6 and D2 mice, and did not significantly alter HIC in female B6 mice. Finasteride pretreatment significantly decreased blood EtOH concentration (BEC) upon initiation of withdrawal, suggesting that finasteride may affect withdrawal severity via an alteration in EtOH pharmacokinetics.

AB - The neurosteroid allopregnanolone (ALLOP) is a very potent positive modulator of γ-aminobutyric acidA (GABAA) receptors that can modulate ethanol (EtOH) withdrawal. The 5α-reductase inhibitor finasteride blocks the formation of ALLOP from progesterone and was recently found to reduce some effects of EtOH. Thus, the present studies were conducted to determine the effect of finasteride on chronic EtOH withdrawal severity in male and female C57BL/6 (B6) and DBA/2 (D2) mice. The animals were exposed to 72 h EtOH vapor or air and received four injections of finasteride (50 mg/kg ip) 24 h prior to, and each day of, the EtOH vapor exposure. Upon removal from the inhalation chambers, handling-induced convulsions (HICs) were measured hourly for the first 12 h and then again at 24 h. EtOH withdrawal severity was significantly greater in D2 than in B6 mice. Pretreatment with finasteride significantly decreased EtOH withdrawal severity only in the female D2 mice, produced a nonselective suppressive effect on HIC in male B6 and D2 mice, and did not significantly alter HIC in female B6 mice. Finasteride pretreatment significantly decreased blood EtOH concentration (BEC) upon initiation of withdrawal, suggesting that finasteride may affect withdrawal severity via an alteration in EtOH pharmacokinetics.

KW - 5α-reductase

KW - Allopregnanolone

KW - C57BL/6

KW - DBA/2

KW - Handling-induced convulsions

KW - Neurosteroid

KW - Withdrawal

UR - http://www.scopus.com/inward/record.url?scp=3142646777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142646777&partnerID=8YFLogxK

U2 - 10.1016/j.pbb.2004.04.016

DO - 10.1016/j.pbb.2004.04.016

M3 - Article

C2 - 15251252

AN - SCOPUS:3142646777

VL - 78

SP - 435

EP - 443

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 3

ER -